Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study

BACKGROUND: Nonalcoholic steatohepatitis (NASH) is an active form of nonalcoholic fatty liver disease. Risk factors for NASH include type 2 diabetes mellitus (T2DM) and obesity. Sodium–glucose cotransporter 2 (SGLT2) inhibitors used to treat T2DM prevent glucose reabsorption in the kidney and increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobita, Hiroshi, Sato, Shuichi, Miyake, Tatsuya, Ishihara, Shunji, Kinoshita, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587885/
https://www.ncbi.nlm.nih.gov/pubmed/28912902
http://dx.doi.org/10.1016/j.curtheres.2017.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587885/
https://www.ncbi.nlm.nih.gov/pubmed/28912902
http://dx.doi.org/10.1016/j.curtheres.2017.07.002

Ejemplares similares